Multimorbidity in Atrial Fibrillation: Impact on Outcomes. [PDF]
Manemann SM +10 more
europepmc +1 more source
Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort. [PDF]
Soler-Espejo E +6 more
europepmc +1 more source
Clinical Impact of Rare Variants in Racial and Ethnic Minorities With Atrial Fibrillation. [PDF]
Hill MC +12 more
europepmc +1 more source
Thrombaxane-B2 as a predictor marker of atrial fibrillation. [PDF]
Petramala L +14 more
europepmc +1 more source
Asundexian Versus Apixaban in Patients With Atrial Fibrillation. [PDF]
Saeed Z +13 more
europepmc +1 more source
Balancing clinical responsibilities and research during electrophysiology fellowship
Panteleimon E. Papakonstantinou, MD, MSc, PhD, FESC
doaj +1 more source
A Year in Review: Atrial Fibrillation 2025. [PDF]
Taranto LM, Karnik AA, Doshi RN.
europepmc +1 more source
Female Sex-Related Stroke Risk in Atrial Fibrillation: A Thing From the Past? [PDF]
Teppo K +10 more
europepmc +1 more source
The role of ubiquitination in the pathogenesis of atrial fibrillation: mechanisms and therapeutic implications. [PDF]
Runtian Z +7 more
europepmc +1 more source
Resolution of long-standing persistent atrial fibrillation after coronary revascularization: a case report on this rare reversible cause of atrial fibrillation. [PDF]
Sukumaran SK +4 more
europepmc +1 more source

